# Tyrosine Vs Tacrolimus With NB-UVB in Vitiligo

> **NCT07532330** · NA · ACTIVE_NOT_RECRUITING · sponsor: **Minia University** · enrollment: 67 (actual)

## Conditions studied

- Vitiligo

## Interventions

- **DEVICE:** Narrowband UVB Phototherapy
- **DRUG:** Topical Tacrolimus 0.1% ointment
- **DRUG:** Topical Tyrosine 2% cream

## Key facts

- **NCT ID:** NCT07532330
- **Lead sponsor:** Minia University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2025-08-01
- **Primary completion:** 2026-02-19
- **Final completion:** 2026-04-10
- **Target enrollment:** 67 (ACTUAL)
- **Last updated:** 2026-04-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07532330

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07532330, "Tyrosine Vs Tacrolimus With NB-UVB in Vitiligo". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT07532330. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*